Malaria in pregnancy forms a substantial part of the worldwide burden of malaria, with an estimated annual death toll of up to 200,000 infants, as well as increased maternal morbidity and mortality. Studies of genetic susceptibility to malaria have so far focused on infant malaria, with only a few studies investigating the genetic basis of placental malaria, focusing only on a limited number of candidate genes. The aim of this study therefore was to identify novel host genetic factors involved in placental malaria infection. To this end we carried out a nested case-control study on 180
Introduction
Malaria in pregnancy is responsible for a substantial part of the annual death toll associated with malaria. It is estimated to cause between 75,000 and 200,000 infant deaths annually, as well as increased maternal mortality (1, 2) . The vast majority of the burden is focused on sub-Saharan Africa, with infection by Plasmodium falciparum being the prime cause. Although adults living in areas of stable transmission are usually to a large extent semi-immune to infection and disease, pregnant women are an exception, particularly during their first pregnancy (3, 4) .
Among the poor outcomes associated with malaria in pregnancy are maternal anaemia, growth retardation of the foetus and prematurity (5) (6) (7) . One characteristic of the pathogenesis of malaria in pregnancy in semi-immune women is infection of the placenta, due to sequestration and accumulation of infected red blood cells (IRBCs) in the intervillous space (8) . Thus, as in the case of infant malaria, cell-adhesion processes are likely to play a central role in the pathogenesis of the disease (9, 10).
There is growing evidence that a glycosaminoglycan receptor, chondroitin sulphate A (CSA), plays a key role in placental sequestration (11) . However, other receptors have also been implicated (12) , and it is likely that additional as of yet unknown factors are also involved (8) .
Malaria in general is a complex disease, with clinical outcome dependent on a variety of host, parasite and environmental factors and their possible interactions.
Nevertheless, it is estimated that host genetic factors account for up to one third of the total variability in susceptibility to the disease. This figure does not include haemoglobin S, the variant with the largest protective effect known to date, which only contributes around 2% to the total variation (13) . Given these numbers, it is safe to assume that the vast majority of host genetic factors involved in susceptibility have yet to be discovered. These discoveries will enable a better understanding of the molecular basis of the pathogenesis of malaria, which can ultimately lead to the identification of new targets for drug and vaccine development. Although numerous studies on genetic susceptibility to malaria exist (e.g. reviewed in 14) , only very few studies so far have investigated the genetic basis of placental malaria infection (e.g. 15, 16) , which may have a very specific physiopathology. The aim of this study was therefore to identify novel host genetic factors involved in placental malaria infection.
To that end, we conducted a case-control study for a set of candidate genes on a sample of pregnant women from Manhiça, Mozambique. Due to the importance of cell-adhesion processes in the pathogenesis of malaria, we decided to focus on genes that are involved in these processes. A common feature of cytoadherence is the involvement of glycan structures in the binding interactions (17) , and glycans are generally thought to play a major role in host-pathogen interactions (18, 19) . We therefore chose to investigate single nucleotide polymorphisms (SNPs) in a set of 49 genes covering the biosynthesis pathways of glycan structures in humans. Our approach is therefore not a simple candidate gene approach but pathway-oriented, covering a full network of genes whose products form the base of an important part of the biosynthesis pathways of glycan structures. Additionally, we also included SNPs from another set of genes related to host-pathogen interaction, consisting of 15 genes involved in innate immunity.
Results

Genotyping, quality control and population structure
After the initial steps of quality control (see Methods), we obtained 355 samples with a total of 719 SNPs with genotype data, from a set of 62 genes. For the remaining quality control steps, all samples and SNPs with call rate below a defined threshold were also eliminated. Samples with low genotype call rates indicate bad DNA quality and unreliable genotypes for a particular sample. We first used more relaxed thresholds in order to maximize the number of samples analyzed, however quality of the resulting data was found to be not sufficient (see Methods for details).
Using more stringent thresholds, we removed all samples with call rate below 0.9 (126), and all SNPs with call rate below 0.9 (58) . The final working set obtained consisted of 597 SNPs in 229 samples, with an average SNP call rate of 0.97. Not surprisingly, inspection of the QQ -plot showed a much improved inflation factor (λ = 1.05, Figure 1 ). All remaining analysis is based on this high -quality dataset.
Due to the fact that undetected population structure in a sample can lead to false positive associations (20) , we used principal component analysis as implemented
in the EIGENSOFT package to analyze the samples. These precautions are necessary because genetic structure of African populations is still poorly known for autosomal loci. ANOVA statistics for population differences along the eigenvectors reported by EIGENSOFT and the inspection of the distribution of the samples along the first two eigenvectors revealed no detectable separation of cases from control samples. Table 1 shows the three SNPs most significantly associated with placental malaria infection in our sample. All of them are located in the FUT9 gene, with one of them (rs3811070) being significant after multiple testing correction (permutation p-value = 0.026), and even after the more conservative Bonferroni correction (Bonferroni p-value = 0.038). The other two are neighbouring SNPs in a block of high linkage disequilibrium (LD) with rs3811070 ( Figure 2) Finally, we carried out haplotypic association analysis on our data using the BEAGLE software package. Haplotypic analysis takes into account the joint distribution of SNPs at a particular locus, and has therefore some advantages over single-SNP analysis, for example in power to detect rare alleles associated with disease (21, 22) . Analysis of all candidate genes revealed one haplotype cluster that showed significance comparable to the single-marker result at rs3811070, albeit marginally not significant after correction for multiple testing (permutation p = 0.077). Not surprisingly, the cluster was found in the FUT9 gene, and included rs3811070. Closer inspection of the cluster revealed that the signal comes from a common haplotype of four SNPs (sequence TTCA; SNPs rs4240595-rs3811070-rs4452646-rs4555922), including the rs3811070 A allele found in the single-marker analysis. Table 3 shows the result of testing for association of all haplotypes observed composed of those four SNPs. As can be seen, there are three different common haplotypes observed in the region, with two of them only differing by one base (ACTC/ACTA). Interestingly, the two most common haplotypes form a yin-yang haplotype pair, showing different alleles at each of the four SNPs. Apart from the strong susceptibility effect observed for the TTCA haplotype, there is also evidence for a protective effect against placental infection of the ACTC haplotype. This is not surprising though, given that both of these haplotypes together have a combined frequency of around 75%. In the remaining five rare haplotypes much smaller differences are found.
Genetic association analysis
In order to get a more detailed view of the haplotype structure defined by the four SNPs, we looked at the region in the HapMap data. . This is clearly opposed to the expected higher diversity and less extensive LD commonly observed in African populations (23, 24) . Furthermore, the combined frequency of the risk type haplotypes is also greater in the Europeans compared to the Africans, with only one observed haplotype of the protective type at a frequency of 0.11 (see Figure 3 ).
Discussion
The aim of this study was to identify host genetic factors involved in placental malaria infection. In particular, we carried out an in-depth analysis of a cellular process with clear information on the functional relationships of the genes involved, namely the biosynthesis of glycan structures. In addition to that, we also analyzed a set of potentially interesting innate immunity genes. Out of the 64 genes analyzed, interactions (17) . In light of this, it is important to note that the fucose added by FucT-IX is always a terminal sugar at the exposed end of the glycan chain, and therefore more prone to be involved in binding interactions than the more internal sugars (31).
This supports the results of this study, as functional variation would also be more likely to be found in the genes related to the addition of terminal residues directly involved in binding, rather than to that of internal ones responsible for the core structure.
Given the importance of cytoadherence and sequestration of infected red blood cells in the pathogenesis of malaria (32, 33) , it is possible that changes in the biosynthesis of Le x can influence the ability of P. falciparum to infect the placenta.
There are several ways in which this might occur. One possibility would be that Le It is important to note that one limitation of our study is the fact that we could only obtain genotypes for the mothers, whereas the receptors expressed on the surface of the syncytiotrophoblast, such as CSA, are derived from foetal tissue and therefore encoded in the genotype of the offspring. This would point towards a role on cells derived from maternal tissue like erythrocytes or leukocytes, rather than the syncytiotrophoblast. Additionally, literature on FUT9 is scarce, due to the fact that it was one of the last fucosyl-transferase genes to be described, and therefore entirely possible that it is involved in other still unknown processes.
From an evolutionary point of view, a variant conferring resistance to the disease and therefore increasing the chance of survival would be expected to show Figure 1 ).
In conclusion, the data shown here suggests that FUT9 is a novel host genetic factor implicated in placental malaria infection. It is important to note that our result stems from a sample of limited size, albeit a sample with very well defined phenotypes from a well-designed epidemiological study. Clearly, follow-up studies will be necessary to confirm and fine-map the signal in the gene region, but mainly to determine functional consequences of the identified risk variants. Our study is therefore only a first attempt to discover host genetic factors involved in placental malaria infection. We hope that our results open the door for other groups to replicate the signal and undertake functional analysis. These discoveries should ultimately help to gain much needed insights into the pathogenesis of this special form of malaria.
Materials and Methods
Study subjects and design
The study was carried out as a nested case-control study of 180 cases and 180 controls. Cases were defined as women who had placental malaria infection at delivery, and controls were women without signs of malaria infection in the placenta.
The study was done in the context of a malaria control intervention trial among pregnant women, which was carried out at the Centro de Investigação em Saúde da (44) for more detail. In order to ensure that there is no bias in the samples selected for the genetic study, we compared a variety of variables potentially related to malaria risk between the groups of women included in the present study and the remaining women of the malaria intervention trial, both for cases and controls. We found no significant differences between the included and excluded groups, even without taking into consideration the multiple testing issue involved (see Supplementary Tables 1a and   1b ).
The study received ethical clearance by the National Mozambican Ethics
Review Committee and the Hospital Clinic of Barcelona Ethics Review Committee.
Candidate genes
A list of 49 genes involved in glycosylation were obtained from data for the biosynthesis pathways of glycan structures from the Kyoto Encyclopedia of Genes and Genomes (KEGG) PATHWAY database (48). This list was augmented with 15 genes involved in innate immunity, resulting in a total of 64 genes (for full list see Supplementary Table 2 ).
Genotyping and data quality control Table 3 ).
DNA for genotyping was obtained by extraction from blood spots on filter paper, followed by whole genome amplification using a GenomiPhi kit by GE Healthcare. Five samples that failed amplification were removed from the subsequent genotyping assay. To avoid potential biases due to batch effects in genotyping, samples were genotyped in a randomized manner without knowledge of case-control status.
All SNPs that completely failed genotyping were removed ( for low quality genotyping data and/or unaccounted for population substructure (50, 51) . Based on the results of the analysis of population structure (see Results), we ruled out that the latter was the cause, and therefore applied more stringent thresholds for the final study set (see Results).
To ensure that no bias in other variables related to malaria risk was introduced by removing the low quality samples, we tested for differences between the included and excluded samples (Supplementary Table 1c ). We only found a significant difference in the malaria season between the two groups. Nonetheless, a test for association between malaria season and case/control status in our final study set was not significant (p = 0.69, Fisher's exact test), therefore ruling out any spurious association due to that variable.
Statistical analysis
Analysis of population structure was carried out using the EIGENSOFT package (version 2.0), with default parameters (52) . Due to the fact that the method assumes that markers are independent, a reduced dataset of 211 SNPs with no LD was used, in addition to the LD correction option implemented in EIGENSOFT. The reduced set was generated using the algorithm implemented in the PLINK package (see below). Quantile-quantile (QQ) -plots and estimation of inflation factors were carried out using the snpMatrix package (53) for the R statistical computing environment (version 2.6.0) (54). LD was analyzed and visualized using Haploview (version 4.0) (55).
Single marker association tests were performed using the SNPator web application (56) as well as the PLINK package (version 1.00) (57 Estimation of ORs and adjusting for covariables were carried out by modelling disease risk within a logistic regression framework, using R. For each SNP, two indicator variables were generated to code for additive and dominance effects.
Additive effects were coded as the number of minor alleles observed in the sample (i.e. homozygous for major allele as the baseline level). Dominance effects were coded as 1 for the heterozygote and 0 otherwise, to reflect departures from the additive model. Covariables that were adjusted for were age (in years) and parity.
Parity was coded in three categories: Primigravidae (P0; baseline level); between one and two pregnancies (P1-2); and three or more pregnancies (P3+). Different models were compared with analysis of deviance, assuming an approximate χ 2 -distribution of the log-likelihood ratio statistic comparing the models (58).
Multi-marker association tests and haplotype phase estimation were performed using the BEAGLE package (version 2. It can also be clearly seen that the YRI show the lowest haplotype diversity of the three populations. Tables   Table 1. Single marker association 
